Renaissance Technologies’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-59,499
| Closed | -$24K | – | 4304 |
|
|
2023
Q3 | $24K | Sell |
59,499
-17,800
| -23% | -$8.77K | ﹤0.01% | 3508 |
|
|
2023
Q2 | $53K | Sell |
77,299
-92,600
| -55% | -$596K | ﹤0.01% | 3608 |
|
|
2023
Q1 | $1.34M | Sell |
169,899
-1,900
| -1% | -$6.62K | ﹤0.01% | 2275 |
|
|
2022
Q4 | $155K | Sell |
171,799
-24,392
| -12% | -$25K | ﹤0.01% | 3497 |
|
|
2022
Q3 | $214K | Sell |
196,191
-13,208
| -6% | -$17.3K | ﹤0.01% | 3356 |
|
|
2022
Q2 | $258K | Buy |
209,399
+24,100
| +13% | +$32.2K | ﹤0.01% | 3533 |
|
|
2022
Q1 | $437K | Buy |
185,299
+6,400
| +4% | +$15.2K | ﹤0.01% | 3267 |
|
|
2021
Q4 | $555K | Sell |
178,899
-22,807
| -11% | -$75.7K | ﹤0.01% | 3026 |
|
|
2021
Q3 | $819K | Sell |
201,706
-55,366
| -22% | -$231K | ﹤0.01% | 2663 |
|
|
2021
Q2 | $1.24M | Buy |
257,072
+23,273
| +10% | +$104K | ﹤0.01% | 2562 |
|
|
2021
Q1 | $1.21M | Buy |
233,799
+19,500
| +9% | +$136K | ﹤0.01% | 2524 |
|
|
2020
Q4 | $1.43M | Sell |
214,299
-34,012
| -14% | -$278K | ﹤0.01% | 2316 |
|
|
2020
Q3 | $2.53M | Sell |
248,311
-49,800
| -17% | -$586K | ﹤0.01% | 1991 |
|
|
2020
Q2 | $3.74M | Buy |
298,111
+148,930
| +100% | +$2.08M | ﹤0.01% | 1820 |
|
|
2020
Q1 | $1.64M | Buy |
149,181
+37,227
| +33% | +$250K | ﹤0.01% | 2163 |
|
|
2019
Q4 | $587K | Buy |
111,954
+8,100
| +8% | +$51.5K | ﹤0.01% | 2840 |
|
|
2019
Q3 | $751K | Buy |
103,854
+8,218
| +9% | +$74.9K | ﹤0.01% | 2704 |
|
|
2019
Q2 | $860K | Buy |
95,636
+7,791
| +9% | +$74.7K | ﹤0.01% | 2754 |
|
|
2019
Q1 | $860K | Buy |
87,845
+4,147
| +5% | +$45.7K | ﹤0.01% | 2736 |
|
|
2018
Q4 | $1.01M | Buy |
83,698
+2,813
| +3% | +$40.8K | ﹤0.01% | 2569 |
|
|
2018
Q3 | $1.31M | Buy |
80,885
+3,605
| +5% | +$85.7K | ﹤0.01% | 2495 |
|
|
2018
Q2 | $2.81M | Buy |
77,280
+8,420
| +12% | +$291K | ﹤0.01% | 2100 |
|
|
2018
Q1 | $2.15M | Buy |
68,860
+7,047
| +11% | +$224K | ﹤0.01% | 2295 |
|
|
2017
Q4 | $2.39M | Buy |
61,813
+12,480
| +25% | +$327K | ﹤0.01% | 2242 |
|
|
2017
Q3 | $1.05M | Buy |
49,333
+8,113
| +20% | +$151K | ﹤0.01% | 2555 |
|
|
2017
Q2 | $829K | Buy |
41,220
+9,393
| +30% | +$194K | ﹤0.01% | 2631 |
|
|
2017
Q1 | $711K | Buy |
31,827
+15,887
| +100% | +$250K | ﹤0.01% | 2660 |
|
|
2016
Q4 | $124K | Buy |
15,940
+12,240
| +331% | +$170K | ﹤0.01% | 3074 |
|
|
2016
Q3 | $78K | Buy |
3,700
+2,320
| +168% | +$56K | ﹤0.01% | 3212 |
|
|
2016
Q2 | $37K | Buy |
+1,380
| New | +$37.8K | ﹤0.01% | 3255 |
|
Other funds holding BLPH
Renaissance Technologies's BLPH Position: Q4 2023 in Review
Renaissance Technologies sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 59,499 shares — an estimated $24K sold.
Renaissance Technologies first reported a position in BLPH in Q2 2016 and held it in 30 quarters. The position peaked at $3.74M in Q2 2020. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.
- Renaissance Technologies reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
- Renaissance Technologies sold 59,499 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $24K.
- Renaissance Technologies first reported a position in Bellerophon Therapeutics, Inc. in Q2 2016 and held it in 30 quarters.
- Renaissance Technologies's Bellerophon Therapeutics, Inc. position peaked at $3.74M in Q2 2020.
- 2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.